TRAIP
Basic information
Region (hg38): 3:49828601-49856574
Links
Phenotypes
GenCC
Source:
- Fanconi anemia complementation group Q (Strong), mode of inheritance: AR
- Seckel syndrome (Supportive), mode of inheritance: AR
- Seckel syndrome 9 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Seckel syndrome 9 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic; Pulmonary | 26595769 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (7 variants)
- Seckel syndrome 9 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRAIP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 29 | 31 | ||||
missense | 40 | 46 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 4 | 6 | 10 | |||
non coding | 24 | 14 | 39 | |||
Total | 7 | 2 | 41 | 59 | 16 |
Highest pathogenic variant AF is 0.0000854
Variants in TRAIP
This is a list of pathogenic ClinVar variants found in the TRAIP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-49828959-C-T | Benign (Nov 12, 2018) | |||
3-49829106-C-T | Likely benign (Jan 20, 2024) | |||
3-49829110-C-A | Uncertain significance (May 27, 2022) | |||
3-49829119-G-T | Uncertain significance (May 06, 2022) | |||
3-49829151-T-G | Seckel syndrome 9 | Benign (Jan 31, 2024) | ||
3-49829169-C-A | Uncertain significance (Jan 27, 2022) | |||
3-49829169-C-T | Likely benign (Nov 07, 2023) | |||
3-49829178-C-T | Likely benign (Sep 13, 2022) | |||
3-49829196-A-G | Likely benign (Jan 11, 2022) | |||
3-49829197-G-C | Uncertain significance (May 25, 2022) | |||
3-49829206-C-T | Inborn genetic diseases | Uncertain significance (Mar 31, 2023) | ||
3-49829207-G-A | Seckel syndrome 9 | Uncertain significance (Aug 07, 2018) | ||
3-49829216-C-T | Inborn genetic diseases | Uncertain significance (Jun 17, 2022) | ||
3-49829221-T-C | Uncertain significance (Apr 01, 2022) | |||
3-49829229-G-A | Likely benign (Nov 24, 2023) | |||
3-49829234-G-A | Benign (Oct 22, 2023) | |||
3-49829239-C-T | Likely benign (Jun 03, 2023) | |||
3-49829448-A-G | Likely benign (Dec 22, 2023) | |||
3-49829461-C-A | Uncertain significance (Aug 12, 2022) | |||
3-49829476-C-G | TRAIP-related disorder | Benign (Nov 27, 2023) | ||
3-49829477-C-T | Uncertain significance (Feb 24, 2023) | |||
3-49829484-C-T | Inborn genetic diseases | Uncertain significance (Jun 05, 2023) | ||
3-49829485-G-A | TRAIP-related disorder | Likely benign (Dec 11, 2023) | ||
3-49829497-G-A | Likely benign (Jan 08, 2024) | |||
3-49829503-C-T | Likely benign (Sep 15, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRAIP | protein_coding | protein_coding | ENST00000331456 | 15 | 27974 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000159 | 0.999 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.32 | 207 | 268 | 0.773 | 0.0000150 | 3069 |
Missense in Polyphen | 48 | 76.122 | 0.63057 | 896 | ||
Synonymous | 1.75 | 80 | 103 | 0.780 | 0.00000535 | 903 |
Loss of Function | 2.79 | 13 | 29.3 | 0.443 | 0.00000151 | 330 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000644 | 0.000644 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000194 | 0.000193 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin ligase acting as a negative regulator of innate immune signaling. Inhibits activation of NF-kappa-B mediated by TNF. Negatively regulates TLR3/4- and RIG-I-mediated IRF3 activation and subsequent IFNB1 production and cellular antiviral response by promoting 'Lys-48'-linked polyubiquitination of TNK1 leading to its proteasomal degradation (By similarity) (PubMed:22945920). Involved in response to genotoxic lesions during genome replication. Promotes H2AX and RPA2 phosphorylation after replication-associated DNA damage and assists fork progression at UV-induced replication-blocking lesions during S phase (PubMed:26595769). Has also been proposed to play a role in promoting translesion synthesis by mediating the assembly of 'Lys- 63'-linked poly-ubiquitin chains on the Y-family polymerase POLN in order to facilitate bypass of DNA lesions and preserve genomic integrity (PubMed:24553286). The function in translesion synthesis is controversial (PubMed:26595769). {ECO:0000250|UniProtKB:Q8VIG6, ECO:0000269|PubMed:22945920, ECO:0000269|PubMed:24553286, ECO:0000269|PubMed:26595769, ECO:0000303|PubMed:26595769}.;
- Disease
- DISEASE: Seckel syndrome 9 (SCKL9) [MIM:616777]: A form of Seckel syndrome, a rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation. {ECO:0000269|PubMed:26595769}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.0801
Intolerance Scores
- loftool
- 0.308
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.0760
- hipred
- Y
- hipred_score
- 0.661
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.885
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Traip
- Phenotype
- cellular phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- apoptotic process;signal transduction;cell population proliferation;negative regulation of tumor necrosis factor-mediated signaling pathway;protein ubiquitination;negative regulation of NF-kappaB transcription factor activity;negative regulation of interferon-beta production
- Cellular component
- nucleolus;perinuclear region of cytoplasm
- Molecular function
- protein binding;metal ion binding;ubiquitin protein ligase activity